This article was automatically translated from the original Turkish version.
The intestine is a vital component of the digestive system and performs essential functions including the digestion and absorption of nutrients and the elimination of waste products from the body. It also plays significant roles in the immune system and overall health. Maintaining intestinal health is crucial for preventing digestive disorders, maximizing nutrient utilization, and reducing the risk of chronic diseases.

Intestine (Generated by Artificial Intelligence)
The intestine is a key part of the digestive system and performs various physiological functions.
One of the primary functions of the intestine is to facilitate the digestion and absorption of nutrients. During this process in the gastrointestinal tract, food nutrients are broken down and released into circulation. The gut microbiota also plays a role in this process by hydrolyzing plant polysaccharides and mucus to provide energy and carbon sources. Bacteria produce short chain fatty acids amines phenols indoles and gases as fermentation products of these hydrolytic compounds.
The intestine is an essential component of the immune system. The gut microbiota plays a critical role in the development and function of the immune system. Interactions between microorganisms in the microbiota and immune cells regulate immune responses.
The dense bacterial community known as the gut microbiota actively participates in various physiological processes. Key functions of the gut microbiota include:
Intestinal physiology is influenced by various factors:
Functional bowel disorders (FBD) are a group of chronic gastrointestinal (GI) diseases characterized by abdominal pain bloating tension and/or abnormalities in bowel habits such as constipation diarrhea or a combination of both. FBDs are defined by criteria including symptom duration of more than six months since onset presence of symptoms during the last three months and occurrence of symptoms at least once per week. A key feature of FBDs is the absence of significant anatomical or physiological abnormalities in routine diagnostic tests. FBDs are classified into five distinct categories: irritable bowel syndrome (IBS) functional constipation (FC) functional diarrhea (FD) functional abdominal bloating/tension and unclassified FBD.
Irritable bowel syndrome (IBS) is an FBD characterized by abdominal pain associated with defecation or accompanied by changes in bowel habits. In individuals with IBS abdominal pain is commonly accompanied by irregular bowel movements (constipation diarrhea or a mixture of both) and abdominal bloating or tension. Symptoms must have begun at least six months before diagnosis and must be present during the last three months. The global prevalence of IBS is estimated at 11.2%. IBS is subdivided into three main subtypes based on predominant bowel habit: constipation-predominant IBS (IBS-C) diarrhea-predominant IBS (IBS-D) and mixed-type IBS (IBS-M).
Functional constipation (FC) is an FBD characterized by difficult infrequent or incomplete defecation. Abdominal pain and/or bloating may be present in functional constipation but are not the dominant symptoms.
Functional diarrhea (FD) is an FBD characterized by frequent passage of abnormally soft or watery stools. For a diagnosis of functional diarrhea it is essential that diarrhea is defined based on stool consistency.
Functional abdominal bloating and tension should be classified as a single condition despite differing symptoms or signs. These conditions may occur independently but are frequently observed together in the same individual.
Opioid-induced constipation (OIC) is a condition associated with opioid use. OIC may present with symptoms similar to functional constipation making it difficult to distinguish between the two conditions.
Inflammatory bowel diseases (IBD) include Crohn's disease and ulcerative colitis both characterized by chronic immune-mediated inflammation. The gut microbiota is believed to play a significant role in the onset and persistence of IBD.
The gut microbiota is thought to trigger or sustain inflammation by providing a pathogenic antigenic source. Alterations in microbiota composition may lead to loss of members that normally induce tolerance in the mucosal immune system against commensal intestinal bacteria.
Various studies have identified a dysbiosis—a disruption in balance—in the gut microbiota of IBD patients. Dysbiosis refers to changes in microbiota composition and diversity. Individuals with Crohn's disease have shown reduced microbiota diversity and alterations in the abundance of certain bacterial species.
Colorectal cancer (CRC) is a malignancy that develops in the intestine. It is often asymptomatic in early stages making screening programs essential for detection. Symptoms such as rectal bleeding iron deficiency anemia changes in bowel habits and unexplained weight loss may indicate colorectal cancer.
Diet is believed to influence the risk of colorectal cancer.
The gut microbiota actively participates in shaping and maintaining human physiology and homeostasis. The intestinal microbiota is referred to as the "second brain" due to its high concentration of bacteria and nerve cells.
The gut microbiota is thought to be associated with various chronic diseases including cancer type 2 diabetes and Alzheimer's disease. Dysbiosis is believed to play a role in the development of some of these conditions.
Intestinal Physiology
Digestion and Absorption
Immune System
Gut Microbiota and Its Functions
Factors Influencing Intestinal Physiology
Intestinal Diseases
Definition and General Features of Functional Bowel Disorders (FBD)
Irritable Bowel Syndrome (IBS)
Functional Constipation
Functional Diarrhea
Functional Abdominal Bloating/Tension
Opioid-Induced Constipation
Relationship Between the Intestine and Inflammatory Diseases
Role of the Gut Microbiota in Inflammatory Bowel Diseases (IBD)
Relationship Between the Intestine and Cancer
Colorectal Cancer
Relationship Between the Gut Microbiota and Overall Health
Role of the Gut Microbiota in Human Physiology
Association Between the Gut Microbiota and Chronic Diseases